CliffBio
biologic

N/A

Venoms, White Faced Hornet Venom Protein

Loss of exclusivityMarch 2036projected — 12-year biologic exclusivity estimate
CompanyJubilant Hollisterstier Llc →View the full company profile on CliffBio

Drug detail

Brand nameN/A
Active ingredientVenoms, White Faced Hornet Venom Protein
Strength100UG/ML
Dosage formFor Injection
RouteSubcutaneous
ModalityBiologic
FDA approvalMarch 2024
Marketing statusRx

More from Jubilant Hollisterstier Llc

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

N/A patent cliff — loss of exclusivity March 2036 | CliffBio